Sonoma Pharmaceuticals (SNOA) P/E (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) P/E from Mar 31, 2011 to Jun 12, 2026. The TTM Sonoma Pharmaceuticals (SNOA) P/E is -0.54. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Sonoma Pharmaceuticals (SNOA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.54 | -70.05% |
| 2025 | -1.80 | +140.45% |
| 2024 | -0.75 | +500.79% |
| 2023 | -0.12 | -81.52% |
| 2022 | -0.67 | -90.15% |
| 2021 | -6.83 | -37.19% |
| 2020 | -10.87 | +66.51% |
| 2019 | -6.53 | +97.18% |
| 2018 | -3.31 | -121.44% |
| 2017 | 15.44 | -254.43% |
| 2016 | -10.00 | -6.46% |
| 2015 | -10.69 | -85.79% |
| 2014 | -75.22 | +181.54% |
| 2013 | -26.72 | -9.43% |
| 2012 | -29.50 | -29.36% |
| 2011 | -41.76 | N/A |
Comparison Sonoma Pharmaceuticals (SNOA) P/E with competitors
Sonoma Pharmaceuticals (SNOA) P/E is -0.54.